Cancer genetics: Two tracks but one race?

Current Biology

Volumn 6, Issue 5, 1996, Pages 523-525

  Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; PROTEIN P16INK4A;

ANIMAL; CELL CYCLE G1 PHASE; EXON; GENETICS; HUMAN; NEOPLASM; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EXONS; G1 PHASE; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASMS;

EID: 0030134239     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(02)00532-8     Document Type: Article

References (22)

1. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993, 366:704-707.
2. Hunter T, Pines J: Cyclins and cancer. Cell 1994, 79:573-582.
3. Morgan DO: Principles of CDK regulation. Nature 1995, 374:131-134.
4. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Old LJ, Stockert E, Day RS, Johnson B, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994, 264:436-440.
5. Hussusian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark WH, Tucker MA, Dracopoli NC: Germline p16 mutations in familial melanoma. Nat Genet 1994, 8:15-21.
6. Caldas C, Hahn SA, da Costa LT, Reston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE: Frequent somatic mutations and homozygous deletions of the p16 (MTS-1) gene in pancreatic adenocarcinoma. Nat Genet 1994, 8:27-32.
7. Serrano M, Gomez-Lahoz E, DePino RA, Beach D, Bar-Sagi D: Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science 1995, 267:249-252.
8. Koh J, Enders GH, Dynlacht BD, Harlow E: Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 1995, 375:506-510.
9. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE, Sidransky D: Low rate of p16 (MTS1) mutations in primary tumors with 9p Loss. Science 1994, 265:415-417.
10. Spruck CH, Gonzales-Zulueta M, Shibata A, Simoneau AR, Lin MF, Gonzales F, Tsai YC, Jones PA: p16 gene in uncultured tumours. Nature 1994, 370:183-184.
11. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, et al.: Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nature Genet 1995, 11:210-212.
12. Merlo A, Herman JG, Mao L, Lee DJ, Schwab D, Burger PC, Baylin SB, Sidransky D: 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995, 7:686-692.
13. INK4A transcript. Cancer Res 1995, 55:2995-2997.
14. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G, Kamb A: Complex structure and regulation of the p16 (MTS-1) locus. Cancer Res 1995, 55:2988-2994.
15. Sheaff RJ, Roberts, JM. Lessons in p16 from phylum falconium. Curr Biol 1995, 1:28-31.
16. CDKN2 expression and its implication for cell immortalization and senescence. Mol Cell Biol 1996, 16:859-867.
17. Quelle DE, Zindy F, Ashmun RA, Sherr CJ: Alternative reading frames of the INK4A tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995, 83:993-1000.
18. Jiang P, Stone S, Wagner R, Wang S, Dayananth P, Kozak CA, Wold B: Comparative analysis of Homo sapiens and Mus musculus cyclin-dependent kinase (CDK) inhibitor genes p16 (MTS-1) and p15 (MTS-2). J Mol Evol 1995, 41:795-802.
19. Lamb RA, Horvath CM. Diversity of coding strategies in influenza viruses. Trends Genet 1991, 7:261-266.
20. Jen J, Harper JW, Bigner SH, Bigner DD: Deletion of p16 and p15 genes in brain tumors. Cancer Res 1995, 54:6353-6358.
21. Glendening JM, Flores JF, Walker GJ, Stone S, Albino AP, Fountain JW: Homozygous loss of the p15(INK4B) gene (and not the p16(INK4A) gene) during tumor progression in a sporadic tumor patient. Cancer Res 1995, 55:5531-5535.
22. INK4B is a potential effector of TGF-β induced cell cycle arrest. Nature 1994, 371:257-261.